Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
- PMID: 25239303
- DOI: 10.1016/j.fertnstert.2014.08.001
Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Abstract
Objective: To study the cardiometabolic profile characteristics and compare the prevalence of cardiovascular (CV) risk factors between women with different polycystic ovary syndrome (PCOS) phenotypes.
Design: A cross-sectional multicenter study analyzing 2,288 well phenotyped women with PCOS.
Setting: Specialized reproductive outpatient clinic.
Patient(s): Women of reproductive age (18-45 years) diagnosed with PCOS.
Intervention(s): Women suspected of oligo- or anovulation underwent a standardized screening consisting of a systematic medical and reproductive history taking, anthropometric measurements, and transvaginal ultrasonography followed by an extensive endocrinologic/metabolic evaluation.
Main outcome measure(s): Differences in cardiometabolic profile characteristics and CV risk factor prevalence between women with different PCOS phenotypes, i.e., obesity/overweight, hypertension, insulin resistance, dyslipidemia, and metabolic syndrome.
Result(s): Women with hyperandrogenic PCOS (n=1,219; 53.3% of total) presented with a worse cardiometabolic profile and a higher prevalence of CV risk factors, such as obesity and overweight, insulin resistance, and metabolic syndrome, compared with women with nonhyperandrogenic PCOS. In women with nonhyperandrogenic PCOS overweight/obesity (28.5%) and dyslipidemia (low-density lipoprotein cholesterol≥3.0 mmol/L; 52.2%) were highly prevalent.
Conclusion(s): Women with hyperandrogenic PCOS have a worse cardiometabolic profile and higher prevalence of CV risk factors compared with women with nonhyperandrogenic PCOS. However, all women with PCOS should be screened for the presence of CV risk factors, since the frequently found derangements at a young age imply an elevated risk for the development of CV disease later in life.
Keywords: Polycystic ovary syndrome; cardiovascular risk.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age.Fertil Steril. 2014 May;101(5):1404-10. doi: 10.1016/j.fertnstert.2014.01.023. Epub 2014 Feb 15. Fertil Steril. 2014. PMID: 24534286 Clinical Trial.
-
Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.Fertil Steril. 2013 Oct;100(4):1081-8. doi: 10.1016/j.fertnstert.2013.06.005. Epub 2013 Jul 2. Fertil Steril. 2013. PMID: 23830153
-
Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.Fertil Steril. 2015 Mar;103(3):795-801.e2. doi: 10.1016/j.fertnstert.2014.12.105. Epub 2015 Jan 10. Fertil Steril. 2015. PMID: 25585504
-
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Hum Reprod Update. 2009 Jul-Aug;15(4):477-88. doi: 10.1093/humupd/dmp008. Epub 2009 Mar 11. Hum Reprod Update. 2009. PMID: 19279045 Review.
-
Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?Semin Reprod Med. 2009 Jul;27(4):299-305. doi: 10.1055/s-0029-1225257. Epub 2009 Jun 15. Semin Reprod Med. 2009. PMID: 19530063 Review.
Cited by
-
Phenotypic Characterization of Patients with Polycystic Ovary Syndrome in a Population from the Ecuadorian Andes: A Cross-Sectional Study.J Clin Med. 2024 Apr 19;13(8):2376. doi: 10.3390/jcm13082376. J Clin Med. 2024. PMID: 38673649 Free PMC article.
-
Stress responses to bacterial and viral mimetics in polycystic ovary syndrome model rats.Brain Behav Immun Health. 2024 Apr 9;38:100772. doi: 10.1016/j.bbih.2024.100772. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38650845 Free PMC article.
-
Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease.Curr Cardiol Rep. 2024 Jun;26(6):483-495. doi: 10.1007/s11886-024-02050-5. Epub 2024 Apr 3. Curr Cardiol Rep. 2024. PMID: 38568339 Review.
-
Reducing the Risk of Pre-Eclampsia in Women with Polycystic Ovary Syndrome Using a Combination of Pregnancy Screening, Lifestyle, and Medical Management Strategies.J Clin Med. 2024 Mar 20;13(6):1774. doi: 10.3390/jcm13061774. J Clin Med. 2024. PMID: 38541997 Free PMC article. Review.
-
PCOS phenotype focus: phenotype D under the magnifying glass.Arch Gynecol Obstet. 2024 Jun;309(6):2307-2313. doi: 10.1007/s00404-024-07408-2. Epub 2024 Mar 19. Arch Gynecol Obstet. 2024. PMID: 38502188 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical